Under construction – not a live service
Sign in
Taking people in ItalyNo phase

EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol

Key facts

Who runs it
MicroPort Orthopedics Inc.
Where
Milan, ItalySee the site
Trial code
Status
Recruiting
People taking part
45 people, planned
Started
31 Oct 2023
Expected to end
Dec 2036
Type of study
Observational
Treatments tested
  • EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert
Record updated
22 January 2024

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Has previously undergone or currently has been determined to undergo a revision knee arthroplasty that requires implantation of the components under study (EVOLUTION® Revision Tibial System and EVOLUTION® STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert)
  • Decision to perform the study index surgery with the required study components is pre-determined regardless of the research
  • Previously implanted subjects must be enrolled within 3 years (+ 6 months) of their study index surgery
  • Willing to voluntarily sign the informed consent form
  • Willing and able to comply with the protocol, able to read and complete the required forms, and willing and able to adhere to the requirements of the protocol through the 10-year postoperative follow-up visit

Who cannot take part

  • Has or had inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable
  • Has or had an overt infection at the time of implantation
  • Has or had an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study
  • Has a medical condition, as judged by the Investigator, that would interfere with the subject's ability to comply with the requirements of the protocol
  • Skeletally immature (less than 21 years of age) at time of implantation
  • Currently enrolled in another clinical investigation which could affect the endpoints of this protocol
  • Has or had documented substance abuse issues
  • Currently incarcerated or has impending incarceration

Where in Italy

  • Gaetano Pini Orthopedic InstituteMilan, ItalyContact: Pietro Randelli, ProfTaking people

About the trial

What the trial wants to find out

MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.

The group in the trial

  • Revision Total Knee Arthroplasty

    Single study group with either newly or previously implanted subjects with the EVOLUTION® Revision Tibia and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Insert.

    Treatment: EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Post Market Clinical Follow-Up Study for EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur With the EVOLUTION® MP CS Tibial Insert
Record updated
22 January 2024